Novavax Ownership | Who Owns Novavax?

Overview Forecast RevenueFinancials Chart Transcripts

Novavax Ownership Summary

Novavax is owned by 35.12% institutional investors, 8.75% insiders, and 56.13% retail investors. Vanguard group is the largest institutional shareholder, holding 9.53% of NVAX shares. State Street® SPDR® S&P® Biotech ETF is the top mutual fund, with 3.50% of its assets in Novavax shares.

NVAX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Novavax	35.12%	8.75%	56.13%
Sector	Healthcare Stocks	232.01%	10.74%	-142.75%
Industry	Biotech Stocks	381.47%	10.55%	-292.02%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	15.47M	9.53%	$103.96M
Shah capital management	14.56M	8.97%	$97.84M
Blackrock	11.85M	8.47%	$149.98M
Blackrock funding, inc. /de	12.90M	7.95%	$86.70M
State street	7.20M	4.44%	$62.40M
Sanofi	6.88M	4.24%	$46.24M
D. e. shaw	5.79M	3.62%	$46.55M
Ubs group	4.89M	3.01%	$32.89M
Coatue management	3.84M	2.37%	$33.27M
Geode capital management	3.72M	2.29%	$25.01M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Shah capital management	14.56M	18.87%	$97.84M
Sanofi	6.88M	14.90%	$46.24M
Tsp capital management group	1.39M	2.28%	$9.33M
Monaco asset management sam	1.04M	1.22%	$7.02M
Crawford fund management	101.00K	0.32%	$1.28M
Headlands	323.03K	0.22%	$2.80M
Virtus investment advisers	62.15K	0.15%	$538.87K
Skaana management	68.30K	0.15%	$458.98K
Eversept partners, lp	243.18K	0.15%	$2.11M
Clarivest asset management	88.74K	0.11%	$1.12M

Top Buyers

Holder	Shares	% Assets	Change
Shah capital management	14.56M	18.87%	2.75M
Morgan stanley	3.72M	0.00%	2.64M
Blackrock	11.85M	0.00%	2.42M
Ubs group	4.89M	0.01%	1.38M
Allianz asset management gmbh	2.32M	0.02%	914.41K

Top Sellers

Holder	Shares	% Assets	Change
Park west asset management	-	-	-2.53M
Renaissance	-	-	-1.20M
Deep track capital, lp	-	-	-998.54K
Perceptive advisors	100.00K	0.03%	-600.00K
Tang capital management	-	-	-600.00K

New Positions

Holder	Shares	% Assets	Change	Value
Nebula research & development	146.53K	0.08%	146.53K	$923.13K
Point72 asset management	96.92K	0.00%	96.92K	$840.27K
Clarivest asset management	88.74K	0.11%	88.74K	$1.12M
Balyasny asset management	82.50K	0.00%	82.50K	$1.04M
Schonfeld strategic advisors	57.95K	0.00%	57.95K	$502.39K

Sold Out

Holder	Change
Wolff wiese magana	-1.00
Global financial private client	-1.00
Raleigh capital management	-2.00
Oarsman capital	-5.00
Financial gravity asset management	-7.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	122	-57.19%	57,021,867	-44.74%	35	0.87%	44	-65.35%	37	-47.14%
Sep 30, 2025	98	-66.44%	29,983,130	-70.63%	18	0.47%	43	-68.38%	26	-51.85%
Jun 30, 2025	290	4.32%	102,039,260	3.62%	62	1.68%	135	14.41%	55	-25.68%
Mar 31, 2025	8	-97.01%	6,659,789	-93.51%	4	0.10%	2	-98.45%	5	-90.20%
Dec 31, 2024	254	-7.64%	94,718,721	1.04%	59	1.73%	118	6.31%	49	-23.44%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
State Street® SPDR® S&P® Biotech ETF	5.69M	3.50%	-30.41K
Vanguard Total Stock Mkt Idx Inv	5.11M	3.14%	-
Vanguard US Total Market Shares ETF	4.86M	3.02%	603.27K
Vanguard Small Cap Index	3.68M	2.27%	10.11K
iShares Russell 2000 ETF	3.60M	2.22%	3.60M
SPDR® S&P Biotech ETF	3.09M	1.91%	6.91K
Vanguard Institutional Extnd Mkt Idx Tr	1.74M	1.07%	7.24K
Fidelity Small Cap Index	1.51M	0.93%	4.00K
Vanguard Small Cap Value Index Inv	1.18M	0.73%	-7.64K
iShares Biotechnology ETF	1.10M	0.67%	124.91K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 13, 2024	King Rachel K.	-	Sell	$37.44K
Dec 31, 2024	YOUNG JAMES F	-	Sell	$43.20K
Dec 24, 2024	YOUNG JAMES F	-	Sell	$39.01K
Jun 21, 2024	YOUNG JAMES F	-	Sell	$105.67K
Jun 18, 2024	YOUNG JAMES F	-	Sell	$15.81K

Insider Transactions Trends

Date	Buy	Sell
2026 Q1	-	-
2025 Q4	-	-
2025 Q2	-	-
2025 Q1	-	-
2024 Q4	-	3

NVAX Ownership FAQ

Who Owns Novavax?

Novavax shareholders are primarily institutional investors at 35.12%, followed by 8.75% insiders and 56.13% retail investors. The average institutional ownership in Novavax's industry, Biotech Stocks , is 381.47%, which Novavax falls below.

Who owns the most shares of Novavax?

Novavax’s largest shareholders are Vanguard group (15.47M shares, 9.53%), Shah capital management (14.56M shares, 8.97%), and Blackrock (11.85M shares, 8.47%). Together, they hold 26.96% of Novavax’s total shares outstanding.

Does Blackrock own Novavax?

Yes, BlackRock owns 8.47% of Novavax, totaling 11.85M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 149.98M$. In the last quarter, BlackRock increased its holdings by 2.42M shares, a 25.65% change.

Who is Novavax’s biggest shareholder by percentage of total assets invested?

Shah capital management is Novavax’s biggest shareholder by percentage of total assets invested, with 18.87% of its assets in 14.56M Novavax shares, valued at 97.84M$.

Who is the top mutual fund holder of Novavax shares?

State Street® SPDR® S&P® Biotech ETF is the top mutual fund holder of Novavax shares, with 3.50% of its total shares outstanding invested in 5.69M Novavax shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools